Skip to main content
. 2017 Jun 14;14(2):1095–1103. doi: 10.3892/etm.2017.4608

Figure 5.

Figure 5.

miR-663b inhibitor-transfected CNE1 cells were further transfected with negative control (NC) siRNA or TUSC2 siRNA, respectively. (A) Quantitative PCR and (B) western blotting was used to examine the mRNA and protein expression of TUSC2. (C) MTT assay, (D) wound healing assay and (E) transwell assay were used to examine the cell proliferation, migration and invasion. **P<0.01 vs. miR-663b inhibitor + NC siRNA. TUSC2, tumor suppressor candidate 2; NC, negative control; siRNA, smal interfering RNA.